Commitment to Quality
Premier Partner of Gene Therapy Medicine Innovators
Veliter Biomedical Technology provides one-stop oligo CDMO Solutions from preclinical to commercial.
Guangdong Veliter Biomedical Technology Co., Ltd was founded in July 2019. Our team is led by experts with specialized knowledge in oligonucleotide process development and manufacturing. We have decades of experience in pre-clinical and clinical development of innovative oligo drug products. Our experts come from globally recognized pharmaceutical enterprises and CDMO firms.
Products & Services
Positive oligo program experience, from end to end
Focusing on your needs and building long-term partnerships, your own Veliter’s project manager will be flexible and responsive. This is Veliter’s approach to make your oligonucleotide program move smoothly through pre-clinical to commercial.
